AMICUS THERAPEUTICS, INC. — Director's Dealing 2021

Jun 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2021-06-10

Reporting Person: ROBERTS EIRY (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-10	Common Stock	A	22759	$0.00	Acquired	22759	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-10	Stock Options (right to buy)	$10.71	A	40625	Acquired	2031-06-10	Common Stock (40625)	Direct

Footnotes

F1: These restricted stock units (RSUs) vest over a period of four years, with 25% vesting on the first anniversary of the grant date and 25% on each anniversary thereafter.

F2: These stock options vest and become exercisable over a period of four years, with 25% vesting on the first anniversary of the date of grant and the remainder vesting ratably each month thereafter.